Adjuvant TherapyAdjuvant chemotherapy for colon cancer is, in the United States, advised routinely for patients found to have involved lymph nodes (Dukes C or stage 3 disease). Local and distant recurrences develop in 30 to 50% of these patients. Standard chemotherapy today includes 5-fluorouracil (5-FU) and levamisole (Ergamisol) (or leucovorin), although many other agents, including irinotecan (CPT-11), are currently being evaluated in clinical trials. In this setting, adjuvant chemotherapy is usually given for 6 to 9 months. For patients with T3 or node-positive rectal cancers who did not undergo preoperative radiotherapy, postoperative radiotherapy (usually 4500 to 5400 cGy) combined with chemotherapy (6 to 9 months) has been shown to increase significantly length of survival and decrease local recurrence rates. Patients with node-positive high rectal cancers (tumor above the peritoneal reflection) are usually advised to undergo chemotherapy alone.
Sarah J. Thompson, MD
Online Diagnosis of Symptoms and Medical Diseases Online Diagnosis of Psychiatric Disorders
Online treatment advisor for medical and psychiatric disorders
|